世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Female Sexual Dysfunction Treatment Market Size study & Forecast, by Type( Arousal Disorder, Penetration Disorder, Female Orgasmic Disorder) by Therapy( Estrogen Therapy, Androgen Therapy and Others), by Age( 25 Years, 25-40 Years and Above 40 Years.), and Regional Analysis, 2022-2029


Global Female Sexual Dysfunction Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 202... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2023年3月6日 US$4,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
200 英語

 

Summary

Global Female Sexual Dysfunction Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Sexual dysfunction is a psychiatric condition characterized by a persistent or recurrent inability to elicit sexual excitement. The Female Sexual Dysfunction Treatment market is expanding because of factors such as increasing incidences of sexual dysfunction among women, rise in the adoption of an unhealthy lifestyle and increase in consumption of alcohol among women.

Rising prevelance of sexual dysfunction among women is driving the market growth. Data from the Blue Cross Blue Shield Association, a federation of 36 different US health insurance firms, showed that approximately 43% of American women were thought to experience female sexual dysfunction on a yearly basis. Furthermore, Safety label changes for female sexual dysfunction therapy and rise in product development activities will accelerate market growth during the forecast period. For instance, in April 2019, US FDA issued a safety labelling change order to Sprout Pharmaceuticals, which needs the company to revise the safety information for Addyi. Similarly, in year 2018, The U.S. Food and Drug Administration (FDA) has approved the use of bremelanotide, a first-in-class melanocortin 4 receptor agonist, to treat premenopausal women with hypoactive sexual desire disorder (HSDD). Moreover, Rise in awareness of the treatment and prevelance of chronic illness among the women is creating a lucrative growth to the market. However, lack of standardization in the treatment of sexual dysfunction stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Female Sexual Dysfunction Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Apricus Biosciences, Inc
GlaxoSmithKline, plc.
Pfizer, Inc.
AMAG Pharmaceuticals
Merck & Co., Inc.
Cipla Inc.
Duchesnay Inc.,
Sprout Pharmaceuticals Inc.
Novo Nordisk AS,
Strategic Science and Technologies LLC


Recent Developments in the Market:
 In June 2019, the US Food and Drug Administration approved Vyleesi (bremelanotide) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
 In June 2018, Pivot Pharmaceuticals Inc. submitted the Clinical Trial Application (CTA) with Health Canada and the Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to start human clinical trials for PVT-005 for the treatment of Female Hypoactive Sexual Desire Disorder (HSDD).



Global Female Sexual Dysfunction Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Therapy, Age, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Arousal Disorder
Penetration Disorder
Female Orgasmic Disorder
By Therapy:
Estrogen Therapy
Androgen Therapy
Others
By Age:
25 Years
25-40 Years
Above 40 Years.



By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Female Sexual Dysfunction Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Female Sexual Dysfunction Treatment Market, by Type, 2019-2029 (USD Billion)
1.2.3. Female Sexual Dysfunction Treatment Market, by Therapy, 2019-2029 (USD Billion)
1.2.4. Female Sexual Dysfunction Treatment Market, by Age, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Female Sexual Dysfunction Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Female Sexual Dysfunction Treatment Market Dynamics
3.1. Female Sexual Dysfunction Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of sexual dysfunction among women
3.1.1.2. Rise in the adoption of an unhealthy lifestyle
3.1.1.3. increase in consumption of alcohol among women
3.1.2. Market Challenges
3.1.2.1. Lack of standardization in the treatment of sexual dysfunction
3.1.3. Market Opportunities
3.1.3.1. Safety label changes for female sexual dysfunction therapy
3.1.3.2. Rise in awareness of the treatment
Chapter 4. Global Female Sexual Dysfunction Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Female Sexual Dysfunction Treatment Market, by Type
6.1. Market Snapshot
6.2. Global Female Sexual Dysfunction Treatment Market by Type, Performance - Potential Analysis
6.3. Global Female Sexual Dysfunction Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Female Sexual Dysfunction Treatment Market, Sub Segment Analysis
6.4.1. Arousal Disorder
6.4.2. Penetration Disorder
6.4.3. Female Orgasmic Disorder
Chapter 7. Global Female Sexual Dysfunction Treatment Market, by Therapy
7.1. Market Snapshot
7.2. Global Female Sexual Dysfunction Treatment Market by Therapy, Performance - Potential Analysis
7.3. Global Female Sexual Dysfunction Treatment Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
7.4. Female Sexual Dysfunction Treatment Market, Sub Segment Analysis
7.4.1. Estrogen Therapy
7.4.2. Androgen Therapy
7.4.3. Others
Chapter 8. Global Female Sexual Dysfunction Treatment Market, by Age
8.1. Market Snapshot
8.2. Global Female Sexual Dysfunction Treatment Market by Age, Performance - Potential Analysis
8.3. Global Female Sexual Dysfunction Treatment Market Estimates & Forecasts by Age 2019-2029 (USD Billion)
8.4. Female Sexual Dysfunction Treatment Market, Sub Segment Analysis
8.4.1. 25 Years
8.4.2. 25-40 Years
8.4.3. Above 40 Years.
Chapter 9. Global Female Sexual Dysfunction Treatment Market, Regional Analysis
9.1. Female Sexual Dysfunction Treatment Market, Regional Market Snapshot
9.2. North America Female Sexual Dysfunction Treatment Market
9.2.1. U.S. Female Sexual Dysfunction Treatment Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Therapy breakdown estimates & forecasts, 2019-2029
9.2.1.3. Age breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Female Sexual Dysfunction Treatment Market
9.3. Europe Female Sexual Dysfunction Treatment Market Snapshot
9.3.1. U.K. Female Sexual Dysfunction Treatment Market
9.3.2. Germany Female Sexual Dysfunction Treatment Market
9.3.3. France Female Sexual Dysfunction Treatment Market
9.3.4. Spain Female Sexual Dysfunction Treatment Market
9.3.5. Italy Female Sexual Dysfunction Treatment Market
9.3.6. Rest of Europe Female Sexual Dysfunction Treatment Market
9.4. Asia-Pacific Female Sexual Dysfunction Treatment Market Snapshot
9.4.1. China Female Sexual Dysfunction Treatment Market
9.4.2. India Female Sexual Dysfunction Treatment Market
9.4.3. Japan Female Sexual Dysfunction Treatment Market
9.4.4. Australia Female Sexual Dysfunction Treatment Market
9.4.5. South Korea Female Sexual Dysfunction Treatment Market
9.4.6. Rest of Asia Pacific Female Sexual Dysfunction Treatment Market
9.5. Latin America Female Sexual Dysfunction Treatment Market Snapshot
9.5.1. Brazil Female Sexual Dysfunction Treatment Market
9.5.2. Mexico Female Sexual Dysfunction Treatment Market
9.5.3. Rest of Latin America Female Sexual Dysfunction Treatment Market
9.6. Rest of The World Female Sexual Dysfunction Treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Apricus Biosciences, Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GlaxoSmithKline, plc.
10.2.3. Pfizer, Inc.
10.2.4. AMAG Pharmaceuticals
10.2.5. Merck & Co., Inc.
10.2.6. Cipla Inc.
10.2.7. Duchesnay Inc.,
10.2.8. Sprout Pharmaceuticals Inc.
10.2.9. Novo Nordisk AS,
10.2.10. Strategic Science and Technologies LLC
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(RFID)の最新刊レポート

Bizwit Research & Consulting LLP社の医療診断分野での最新刊レポート

本レポートと同じKEY WORD(dysfunction treatment)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る